John Neuman
Independent DirectorMr. John Neuman is Independent Director of SeaStar Medical Holding Corporation from June 05, 2024. Mr. Neuman served at Dow Chemical Company ("Dow") until 2023 following 30 years of service. He served as Vice President of Global Financial Accounting at Dow, directing a global team of more than 350 team members. Additionally, Mr. Neuman provided oversight and direction for Corporate Controllers and for Mumbai Global Accounting. He joined Dow in 1993 and held various positions in Finance, including roles in corporate auditing, corporate controllers, business finance and controllers. His business finance role included a five-year international assignment in Switzerland. His tenure at Dow included finance integration and reporting responsibilities for several M&A transactions, including the Rohm & Haas and Dow Corning acquisitions and the DowDuPont merger. Prior to joining Dow, Mr. Neuman worked as an audit manager for Deloitte & Touche LLP. He holds a degree in accounting from Michigan State University, is a CPA and has served as a member of the MSU External Advisory Board for the Department of Accounting and Information Systems.
Positions
- Company NameSeaStar Medical Holding CorporationStock CodeICUPositionIndependent DirectorRelated SecuritiesColleagues
- ESEric SchlorffCEO, Treasurer, President & Executive Director
- JAJennifer A. BairdIndependent Chairman of the Board
- MMMichael MessingerChief Financial Officer
- KCKevin ChungChief Medical Officer
- HDH. David HumesCo-Founder & Scientific Advisor
- TMTom MullenVice President of Operations & Product Development
- GMGlenn Matthew ChertowMember of Medical Advisory Board
- RLRavindra L. MehtaMember of Medical Advisory Board
